From the publisher:
Gilda Radner, the popular star of "Saturday Night Live", died of ovarian cancer on May 20, 1989. When "Fighting Ovarian Cancer - Doctors Don't Know Who's at Risk, or Why" appeared in the Washington Post ten days later, the media had finally let ovarian cancer out of the closet. It could strike any woman, including a famous comedienne who meant so much to so many. Following the publication in the New York Times of medical writer Larry Altman's article "Research Links Diet and Infertility Factors to Ovarian Cancer," Gilda's husband, Gene Wilder, wrote to the author to ask some pointed questions. Altman urged him to contact Dr. M. Steven Piver at the Roswell Park Cancer Institute in Buffalo, New York. Wilder and Piver met over the phone and immediately recognized their shared common desire. From that time, they have worked together to communicate to the general public what is now known about ovarian cancer. When Dr. Piver decided to write Gilda's Disease, he asked Wilder to help him by sharing what he had learned during Gilda's struggle so that others might benefit from their ordeal.
From Publisher's Weekly:
After the death of comedienne Gilda Radner from ovarian cancer in 1989, her husband, Gene Wilder, contacted Piver, chief of gynecological oncology at Roswell Park Cancer Institute in Buffalo, N.Y., to learn more about the disease that killed his wife. In this overview of ovarian cancer, Piver outlines known causes, preventive measures, symptoms and available treatments for this disease. Interspersed with the medical information are excerpts from Radner's book, It's Always Something, written when she was under treatment; personal comments by Wilder; and letters from other women who have been treated for this condition. Because in its early stages, ovarian cancer can be symptom-free, this straightforward, textbook-like presentation is useful. Photos not seen by PW. (Sept.) FYI: All royalties will be contributed to two agencies for women with ovarian cancer: Gilda's Club and the Gilda Radner Familial Ovarian Cancer Registry.
I was reluctant to pick up this book, being familiar with Gilda's hard struggle with OVCA, but when I saw it was filled with a large amount of information regarding the disease, I was intrigued. Coincidentally I had just received a packet from the Gilda Radner Familial Ovarian Cancer Registry to fill out to place my family there. It's been hard for me to understand all of the details of diagnosis and familial links, but this book has cleared up a lot of questions I had. It's one of the few resources that I've read from front to back, and I now know what "debulking" and "second line chemotherapy" are, and what a number of the newer chemo drugs are called. Although I had read about the chemo drugs I was given, and had them described, this book goes into their history and just why they're used! I highly recommend it to those who suspect OVCA, those who have it, and anyone who has an interest in learning more about it.